身价超20亿生物制造公司被收购！合作过爱马仕、凯迪拉克

Core Viewpoint - MycoWorks, a pioneer in sustainable mycelium leather, has been acquired by DFX Corp, aiming for business restructuring and expansion with significant backing from high-profile investors [2][4]. Group 1: Company Overview - MycoWorks has achieved commercial success over its eight years, collaborating with luxury brands like Hermès and Cadillac, with a pre-acquisition valuation of $300 million (approximately 2 billion RMB) [2]. - The company closed its self-built biomanufacturing facility in the U.S. last November, shifting from in-house mycelium cultivation to sourcing materials from external suppliers in Eurasia [4]. - CEO Matthew Scullin noted that the production model faced cost challenges in the current market environment, leading to a strategic pivot towards material processing and increased investment in Rei-Tan tanning technology [5]. Group 2: Industry Insights - China is positioned to lead in the large-scale application of bio-based leather within 3-5 years, with significant discussions at the Sustainable Application Forum focusing on commercialization timelines [6][9]. - Experts predict that bio-based leather will see widespread adoption in the casual footwear and bag sectors within 3-5 years, partial application in the automotive sector, and full integration as a luxury leather alternative may take over 10 years [9]. - SynMetabio is recognized as a leader in low-carbon bio-based leather production, with an annual production capacity of 6 million meters, expected to reach 20 million meters by 2026 [10]. Group 3: Future Events and Developments - The 11th Bio-based Industry Conference & Exhibition is scheduled for May 20-22, 2026, in Shanghai, aiming to foster collaboration and innovation in the bio-based materials sector [16][17]. - The event will feature 11 thematic forums and 7 concurrent activities, including the DT New Leaf Award, which recognizes innovation in the bio-based industry [17].